PUBLISHER: Polaris Market Research | PRODUCT CODE: 1651981
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1651981
The global prefilled syringes market size is expected to reach USD 26.87 billion by 2034, according to a new study by Polaris Market Research. The report "Prefilled Syringes Market Size, Share, Trends, Industry Analysis Report: By Material (Glass and Plastic), Closing System, Product, Design, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The prefilled syringes market expansion is driven by factors such as the increasing demand for biologics, rising chronic disease management, and the shift toward self-administration of injectable drugs. Other key drivers include advancements in drug delivery systems, improved safety features, and the need for precise, reliable dosing to enhance patient compliance. The prefilled syringes market opportunities lie in expanding production capabilities in emerging markets and developing innovative syringe designs, such as multi-chamber and needle-free systems.
Trends such as sustainability and the use of eco-friendly materials are gaining traction, alongside growing regulatory focus on safety and quality standards. With the rising prevalence of chronic conditions and the increasing focus on biologic treatments, the market is expected to continue its upward trajectory, offering significant growth prospects for established players and new entrants.
By material, the glass segment holds a larger prefilled syringes market share due to their superior chemical resistance and compatibility with biologics. However, the plastic segment is experiencing higher growth, driven by their lightweight, durability, and cost-effective properties.
Based on closing system, the staked needle system segment dominates the market due to its convenience and widespread use, especially in vaccines and biologics. The luer lock form systems segment is growing fastest due to their enhanced safety and secure connection, especially for high-pressure injections.
By product, the complete syringe sets segment holds a larger market share due to their pre-assembled, ready-to-use nature. However, the components & accessories segment is growing faster, driven by increasing demand for customized syringe solutions in drug delivery.
The single-chamber segment, by design dominates the prefilled syringes market revenue share due to their simplicity and broad application in various drug formulations. The double-chamber segment is witnessing the highest growth, particularly for biologics and reconstitute drugs.
In terms of end user, the pharmaceutical & biotechnology companies segment holds the largest share, driven by the growing demand for biologics and vaccines. The contract research & manufacturing organizations segment is experiencing the highest growth due to their increasing role in outsourcing drug development and production.
Europe dominates the prefilled syringes market due to its advanced healthcare infrastructure and regulatory standards. However, Asia Pacific is registering the highest growth, driven by improving healthcare access and the rising prevalence of chronic diseases in emerging markets.
Polaris Market Research has segmented the prefilled syringes market report based on material, closing system, product, design, end user, and region: